Long-term improvements in physical function are associated with improvements in dactylitis, enthesitis, tender and swollen joint counts, and psoriasis skin involvement: Results from a phase 3 study of ustekinumab in psoriatic arthritis patients - 09/05/15
Alice Gottlieb, MD, PhD, Tufts Medical Center, Boston, MA, United States; Lluis Puig, MD, Universitat Autònoma de Barcelona, Barcelona, Spain; Arthur Kavanaugh, MD, University of California-San Diego, La Jolla, CA, United States; Christopher Ritchlin, MD, University of Rochester, Rochester, NY, United States; Shu Li, PhD, Janssen Research & Development, LLC., Spring House, PA, United States; Yin You, PhD, Janssen Research and Development, LLC, Spring House, PA, United States; Alan M. Mendelsohn, MD, Janssen Research & Development, LLC, Spring House, PA, United States; Michael Song, MD, Janssen Research and Development, LLC, Spring House, PA, United States; Proton Rahman, MD, Memorial University, Newfoundland and Labrador, Newfoundland, Canada; Iain B. McInnes, MD, University of Glasgow, Glasgow, United Kingdom
Le texte complet de cet article est disponible en PDF.| 100% is Sponsored by Janssen Scientific Affairs, LLC. |
Vol 72 - N° 5S1
P. AB239 - mai 2015 Retour au numéro
Article précédent
- Lichen planus pigmentosus-inversus: A rare variant of lichen planus
- Long-term data regarding the use of fumarates in psoriasis: Preliminary study results from Germany
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?